CalciMedica, Inc. (NASDAQ:CALC) Financings

CalciMedica, Inc.

Financings

RaiseDate
Private placement of units of common stock or pre-funded warrants with Series A and Series B warrant rights
Announced: US$15M–US$49M · US$0.8033 a unit · a right to receive one Series A warrant exercisable at $0.8033 per share and one… · Guggenheim Securities, LLC
Dealers: Guggenheim Securities, LLC (lead)
Insiders: Members of the Board of Directors and management team participate, priced at or above the Nasdaq Consolidated Closing Bid Price as of June 23, 2026
Use of proceeds: Pulmonary hypertension program: Phase 1b study of Auxora in PAH, IND-enabling work for CM5480, and general corporate purposes
Jun 24, 2026

Read by 6ix AI from the company's releases